Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GET73 in Recently Abstinent Alcohol Use Disorder
NCT03418623Phase 2Completed
- Sponsor
- Laboratorio Farmaceutico CT
- Start
- Mar 2018
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GET-73 in alcohol use disorder (AUD), sponsored by Laboratorio Farmaceutico CT. Started Mar 2018; status: completed.
02
Drugs
GET-73
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT03418623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03418623.